Literature DB >> 21326283

Differential secretion of the mutated protein is a major component affecting phenotypic severity in CRLF1-associated disorders.

Jana Herholz1, Alessandra Meloni, Mara Marongiu, Francesca Chiappe, Manila Deiana, Carmen Roche Herrero, Giuseppe Zampino, Hanan Hamamy, Yusra Zalloum, Per Erik Waaler, Giangiorgio Crisponi, Laura Crisponi, Frank Rutsch.   

Abstract

Crisponi syndrome (CS) and cold-induced sweating syndrome type 1 (CISS1) are disorders caused by mutations in CRLF1. The two syndromes share clinical characteristics, such as dysmorphic features, muscle contractions, scoliosis and cold-induced sweating, with CS patients showing a severe clinical course in infancy involving hyperthermia, associated with death in most cases in the first years of life. To evaluate a potential genotype/phenotype correlation and whether CS and CISS1 represent two allelic diseases or manifestations at different ages of the same disorder, we carried out a detailed clinical analysis of 19 patients carrying mutations in CRLF1. We studied the functional significance of the mutations found in CRLF1, providing evidence that phenotypic severity of the two disorders mainly depends on altered kinetics of secretion of the mutated CRLF1 protein. On the basis of these findings, we believe that the two syndromes, CS and CISS1, represent manifestations of the same disorder, with different degrees of severity. We suggest renaming the two genetic entities CS and CISS1 with the broader term of Sohar-Crisponi syndrome.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21326283      PMCID: PMC3083629          DOI: 10.1038/ejhg.2010.253

Source DB:  PubMed          Journal:  Eur J Hum Genet        ISSN: 1018-4813            Impact factor:   4.246


  27 in total

1.  Successful treatment of cold-induced sweating in Crisponi syndrome and its possible mechanism of action.

Authors:  Jana Herholz; Laura Crisponi; Birendra N Mallick; Frank Rutsch
Journal:  Dev Med Child Neurol       Date:  2010-02-24       Impact factor: 5.449

2.  Stüve-Wiedemann syndrome: update and historical footnote.

Authors:  H R Wiedemann; A Stüve
Journal:  Am J Med Genet       Date:  1996-05-03

3.  Autosomal recessive disorder with muscle contractions resembling neonatal tetanus, characteristic face, camptodactyly, hyperthermia, and sudden death: a new syndrome?

Authors:  G Crisponi
Journal:  Am J Med Genet       Date:  1996-04-24

4.  On lumpers and splitters, or the nosology of genetic disease.

Authors:  V A McKusick
Journal:  Perspect Biol Med       Date:  1969       Impact factor: 1.416

5.  Cold-induced profuse sweating on back and chest. A new genetic entity?

Authors:  E Sohar; Y Shoenfeld; R Udassin; A Magazanik; M Revach
Journal:  Lancet       Date:  1978-11-18       Impact factor: 79.321

6.  Stüve-Wiedemann syndrome and defects of the mitochondrial respiratory chain.

Authors:  B Chabrol; S Sigaudy; V Paquis; M F Montfort; H Giudicelli; J F Pellissier; V Millet; J Mancini; N Philip
Journal:  Am J Med Genet       Date:  1997-10-17

7.  Stüve-Wiedemann dysplasia in a 3 1/2-year-old boy.

Authors:  K Kozlowski; R Tenconi
Journal:  Am J Med Genet       Date:  1996-05-03

8.  Mice lacking the CNTF receptor, unlike mice lacking CNTF, exhibit profound motor neuron deficits at birth.

Authors:  T M DeChiara; R Vejsada; W T Poueymirou; A Acheson; C Suri; J C Conover; B Friedman; J McClain; L Pan; N Stahl; N Y Ip; G D Yancopoulos
Journal:  Cell       Date:  1995-10-20       Impact factor: 41.582

9.  Null leukemia inhibitory factor receptor (LIFR) mutations in Stuve-Wiedemann/Schwartz-Jampel type 2 syndrome.

Authors:  Nathalie Dagoneau; Deborah Scheffer; Céline Huber; Lihadh I Al-Gazali; Maja Di Rocco; Anne Godard; Jelena Martinovic; Annick Raas-Rothschild; Sabine Sigaudy; Sheila Unger; Sophie Nicole; Bertrand Fontaine; Jean-Luc Taupin; Jean-François Moreau; Andrea Superti-Furga; Martine Le Merrer; Jacky Bonaventure; Arnold Munnich; Laurence Legeai-Mallet; Valérie Cormier-Daire
Journal:  Am J Hum Genet       Date:  2004-01-21       Impact factor: 11.025

10.  Clinical homogeneity of the Stüve-Wiedemann syndrome and overlap with the Schwartz-Jampel syndrome type 2.

Authors:  V Cormier-Daire; A Superti-Furga; A Munnich; S Lyonnet; P Rustin; A L Delezoide; P De Lonlay; A Giedion; P Maroteaux; M Le Merrer
Journal:  Am J Med Genet       Date:  1998-06-30
View more
  11 in total

1.  Cytokine-like factor 1 gene expression is enriched in idiopathic pulmonary fibrosis and drives the accumulation of CD4+ T cells in murine lungs: evidence for an antifibrotic role in bleomycin injury.

Authors:  Daniel J Kass; Guoying Yu; Katrina S Loh; Asaf Savir; Alain Borczuk; Rehan Kahloon; Brenda Juan-Guardela; Giuseppe Deiuliis; John Tedrow; Jiin Choi; Thomas Richards; Naftali Kaminski; Steven M Greenberg
Journal:  Am J Pathol       Date:  2012-03-16       Impact factor: 4.307

Review 2.  Cytokine-like factor 1 (CLF1): life after development?

Authors:  Daniel J Kass
Journal:  Cytokine       Date:  2011-06-28       Impact factor: 3.861

3.  Neuropathies of Stüve-Wiedemann Syndrome due to mutations in leukemia inhibitory factor receptor (LIFR) gene.

Authors:  Alexandra E Oxford; Cheryl L Jorcyk; Julia Thom Oxford
Journal:  J Neurol Neuromedicine       Date:  2016

4.  Stratified polygenic risk prediction model with application to CAGI bipolar disorder sequencing data.

Authors:  Maggie Haitian Wang; Billy Chang; Rui Sun; Inchi Hu; Xiaoxuan Xia; William Ka Kei Wu; Ka Chun Chong; Benny Chung-Ying Zee
Journal:  Hum Mutat       Date:  2017-06-13       Impact factor: 4.878

5.  Role of cytokine receptor-like factor 1 in hepatic stellate cells and fibrosis.

Authors:  Lela Stefanovic; Branko Stefanovic
Journal:  World J Hepatol       Date:  2012-12-27

6.  Cold induced sweating syndrome with urinary system anomaly association.

Authors:  Salim Aljabari; Emily Howard; Todd Bell; Tetyana L Vasylyeva
Journal:  Case Rep Pediatr       Date:  2013-08-29

Review 7.  Stüve-Wiedemann syndrome: LIFR and associated cytokines in clinical course and etiology.

Authors:  Dawn Mikelonis; Cheryl L Jorcyk; Ken Tawara; Julia Thom Oxford
Journal:  Orphanet J Rare Dis       Date:  2014-03-12       Impact factor: 4.123

8.  Cytokine-Like Factor 1, an Essential Facilitator of Cardiotrophin-Like Cytokine:Ciliary Neurotrophic Factor Receptor α Signaling and sorLA-Mediated Turnover.

Authors:  Jakob Vejby Larsen; Anders Mejer Kristensen; Lone Tjener Pallesen; Johannes Bauer; Christian Bjerggaard Vægter; Morten Schallburg Nielsen; Peder Madsen; Claus Munck Petersen
Journal:  Mol Cell Biol       Date:  2016-03-31       Impact factor: 4.272

9.  Effect of human very low-density lipoproteins on cardiotrophin-like cytokine factor 1 (CLCF1) activity.

Authors:  Sarah Pasquin; Salma Chehboun; Agnieszka Dejda; Yasmine Meliani; Virginia Savin; Gregory J Warner; Roger Bosse; Aurélie Tormo; Gaétan Mayer; Mukut Sharma; Przemyslaw Sapieha; Catherine Martel; Jean-François Gauchat
Journal:  Sci Rep       Date:  2018-03-05       Impact factor: 4.379

10.  Cytokine receptor-like factor 1 (CRLF1) protects against 6-hydroxydopamine toxicity independent of the gp130/JAK signaling pathway.

Authors:  Brendan D Looyenga; James Resau; Jeffrey P MacKeigan
Journal:  PLoS One       Date:  2013-06-20       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.